/CGNX
CGNX Stock - Cognex Corporation
Technology|Hardware, Equipment & PartsNASDAQ
$36.80+1.74%
+$0.63 (+1.74%) • Dec 19
67
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.39
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).100
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.59
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+32.6%upside
Target: $48.80
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for CGNX
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$36.43 – $37.17
TARGET (TP)$48.78
STOP LOSS$33.86
RISK/REWARD1:4.1
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta1.52
52W High$49.76
52W Low$22.67
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $914.51M | $837.55M | $1.01B | $1.04B | $811.02M |
| Gross Profit | $625.79M | $601.24M | $721.90M | $759.83M | $604.60M |
| Gross Margin | 68.4% | 71.8% | 71.8% | 73.3% | 74.5% |
| Operating Income | $115.06M | $130.70M | $246.23M | $315.10M | $170.53M |
| Net Income | $106.17M | $113.23M | $215.53M | $279.88M | $176.19M |
| Net Margin | 11.6% | 13.5% | 21.4% | 27.0% | 21.7% |
| EPS | $0.62 | $0.66 | $1.24 | $1.59 | $1.02 |
Company Overview
Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process. The company offers VisionPro software, a suite of patented vision tools for advanced programming; QuickBuild that allows customers to build vision applications with a graphical, flowchart-based programming interface; and Cognex deep learning vision software. It also provides a range of inspection tasks, including part location, identification, measurement, assembly verification, and robotic guidance; vision sensors for vision applications, such as checking the presence and size of parts; and the In-Sight product line of vision systems and sensors. In addition, the company offers DataMan, an image-based barcode readers and barcode verifiers. It sells its products to consumer electronics, automotive, consumer products, food and beverage, pharmaceuticals, and medical devices industries, as well as through a network of distributors and integrators. Cognex Corporation was incorporated in 1981 and is headquartered in Natick, Massachusetts.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
10
56%
Hold / Neutral
7
39%
Sell / Underperform
1
6%
Analyst Consensus🟡 Mixed
10 Bullish8 Neutral/Bearish
Price Targets
$48
Average Target
↑ 31.1% Upside
Now
$33
Low
$48
Average
$65
High
Based on 24 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| December 16th 2025 | Goldman | Upgrade | Buy | $50 |
| December 3rd 2025 | JP Morgan | Downgrade | Underweight | $35 |
| October 8th 2025 | Barclays | Initiation | Overweight | $55 |
| September 15th 2025 | JP Morgan | Initiation | Neutral | $45 |
| August 1st 2025 | KeyBanc Capital Markets | Upgrade | Overweight | $50 |
| July 10th 2025 | Melius | Upgrade | Buy | $60 |
| April 28th 2025 | TD Cowen | Upgrade | Buy | $35 |
| February 21st 2025 | HSBC Securities | Downgrade | Hold | $33 |
| December 20th 2024 | Cantor Fitzgerald | Initiation | Overweight | $49 |
| November 5th 2024 | Truist | Downgrade | Hold | $43← $46 |
| October 16th 2024 | Stephens | Upgrade | Overweight | $55← $45 |
| July 29th 2024 | Needham | Reiterated | Buy | $57← $48 |
| July 23rd 2024 | Vertical Research | Initiation | Buy | $58 |
| May 7th 2024 | HSBC Securities | Upgrade | Buy | - |
| March 19th 2024 | UBS | Upgrade | Buy | $54← $42 |
Earnings History & Surprises
CGNXBeat Rate
78%
Last 18 quarters
Avg Surprise
+15.2%
EPS vs Estimate
Beats / Misses
14/2
2 met exactly
Latest EPS
$0.33
Q4 2025
EPS Surprise History
Q1 24
0.0%
$0.11vs$0.11
Q2 24
+37.5%
$0.11vs$0.08
Q3 24
+9.5%
$0.23vs$0.21
Q4 24
+5.3%
$0.20vs$0.19
Q1 25
+33.3%
$0.20vs$0.15
Q2 25
+23.1%
$0.16vs$0.13
Q3 25
+8.7%
$0.25vs$0.23
Q4 25
+22.2%
$0.33vs$0.27
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 28, 2026 | — | — | — | — |
Q1 2026 | Feb 11, 2026 | $0.22 | — | — | — |
Q4 2025 | Oct 29, 2025 | $0.27 | $0.33 | +22.2% | ✓ BEAT |
Q3 2025 | Jul 30, 2025 | $0.23 | $0.25 | +8.7% | ✓ BEAT |
Q2 2025 | Apr 30, 2025 | $0.13 | $0.16 | +23.1% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $0.15 | $0.20 | +33.3% | ✓ BEAT |
Q4 2024 | Oct 30, 2024 | $0.19 | $0.20 | +5.3% | ✓ BEAT |
Q3 2024 | Jul 31, 2024 | $0.21 | $0.23 | +9.5% | ✓ BEAT |
Q2 2024 | May 2, 2024 | $0.08 | $0.11 | +37.5% | ✓ BEAT |
Q1 2024 | Feb 15, 2024 | $0.11 | $0.11 | 0.0% | = MET |
Q4 2023 | Oct 31, 2023 | $0.15 | $0.16 | +6.7% | ✓ BEAT |
Q3 2023 | Aug 3, 2023 | $0.28 | $0.32 | +14.3% | ✓ BEAT |
Q2 2023 | May 4, 2023 | $0.09 | $0.13 | +44.4% | ✓ BEAT |
Q1 2023 | Feb 16, 2023 | $0.32 | $0.27 | -15.6% | ✗ MISS |
Q4 2022 | Nov 3, 2022 | $0.14 | $0.21 | +50.0% | ✓ BEAT |
Q3 2022 | Aug 2, 2022 | $0.41 | $0.41 | 0.0% | = MET |
Q2 2022 | May 5, 2022 | $0.39 | $0.42 | +7.7% | ✓ BEAT |
Q1 2022 | Feb 17, 2022 | $0.22 | $0.30 | +36.4% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $0.46 | $0.40 | -13.0% | ✗ MISS |
Q3 2021 | Aug 5, 2021 | $0.42 | $0.43 | +2.4% | ✓ BEAT |
Latest News
Truist Securities Maintains Hold on Cognex, Lowers Price Target to $42
➖ NeutralBenzinga•Dec 18, 2025, 02:22 PM
Cognex shares are trading higher after Goldman Sachs upgraded the stock from Sell to Buy and raised its price target from $42 to $50.
📈 PositiveBenzinga•Dec 16, 2025, 12:59 PM
Goldman Sachs Upgrades Cognex to Buy, Raises Price Target to $50
📈 PositiveBenzinga•Dec 16, 2025, 11:40 AM
JP Morgan Downgrades Cognex to Underweight, Lowers Price Target to $35
📉 NegativeBenzinga•Dec 3, 2025, 12:50 PM
DA Davidson Maintains Neutral on Cognex, Raises Price Target to $38
➖ NeutralBenzinga•Nov 3, 2025, 06:22 PM
Barclays Maintains Overweight on Cognex, Raises Price Target to $56
📈 PositiveBenzinga•Oct 31, 2025, 03:27 PM•Also:
Needham Maintains Buy on Cognex, Raises Price Target to $47
📈 PositiveBenzinga•Oct 31, 2025, 09:45 AM
Cognex shares are trading lower. The company reported Q3 financial results.
📉 NegativeBenzinga•Oct 30, 2025, 03:18 PM
Cognex Non-GAAP EPS of $0.33 beats by $0.04, revenue of $277M beats by $15.11M
📈 PositiveSeeking Alpha•Oct 29, 2025, 08:35 PM
Cognex Sees Q4 Adj EPS $0.19-$0.24 vs $0.22 Est; Sees Sales $230M-$245M vs $236.867M Est
➖ NeutralBenzinga•Oct 29, 2025, 08:33 PM
Cognex Q3 Adj. EPS $0.33 Beats $0.29 Estimate, Sales $276.892M Beat $262.261M Estimate
📈 PositiveBenzinga•Oct 29, 2025, 08:31 PM
Cognex gains after activst Engaged Capital reports stake
📈 PositiveSeeking Alpha•Oct 21, 2025, 07:25 PM
Activist Engaged Built Stake In Cognex, Says Stock Could Double In Two Years With Cost Cuts
📈 PositiveBenzinga•Oct 21, 2025, 06:24 PM
Truist Securities Maintains Hold on Cognex, Raises Price Target to $45
➖ NeutralBenzinga•Oct 8, 2025, 02:02 PM
Goldman Sachs Maintains Sell on Cognex, Raises Price Target to $40
➖ NeutralBenzinga•Sep 16, 2025, 04:55 PM
JP Morgan Initiates Coverage On Cognex with Neutral Rating, Announces Price Target of $45
➖ NeutralBenzinga•Sep 15, 2025, 10:56 AM•Also:
Frequently Asked Questions about CGNX
What is CGNX's current stock price?
Cognex Corporation (CGNX) is currently trading at $36.80 per share. The stock has moved +1.74% today.
What is the analyst price target for CGNX?
The average analyst price target for CGNX is $48.78, based on 1 analyst.
What sector is Cognex Corporation in?
Cognex Corporation operates in the Technology sector, specifically within the Hardware, Equipment & Parts industry. The company is traded on the NASDAQ exchange.
What is CGNX's market cap?
Cognex Corporation has a market capitalization of $6.17 billion, making it a mid-cap company.
Does CGNX pay dividends?
No, Cognex Corporation does not currently pay a dividend to shareholders.
Similar Stocks
Technology SectorBMI
Badger Meter, Inc.
$181.64
Mkt Cap: $5.4B
DSGX
The Descartes Systems Group Inc.
$89.51
Mkt Cap: $7.7B
ESE
ESCO Technologies Inc.
$198.78
Mkt Cap: $5.1B
LFUS
Littelfuse, Inc.
$255.00
Mkt Cap: $6.3B
NOVT
Novanta Inc.
$119.35
Mkt Cap: $4.3B
OLED
Universal Display Corporation
$116.95
Mkt Cap: $5.6B
SANM
Sanmina Corporation
$151.52
Mkt Cap: $8.2B
TTMI
TTM Technologies, Inc.
$70.38
Mkt Cap: $7.3B
VNT
Vontier Corporation
$37.86
Mkt Cap: $5.5B
WAY
Waystar Holding Corp.
$32.84
Mkt Cap: $5.7B
Explore stocks similar to CGNX for comparison